A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

NCT05358379 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult Lymphoma

Interventions

DRUG: CYC140

Sponsor

Cyclacel Pharmaceuticals, Inc.